MedPath

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States
Ownership
-
Established
1811-01-01
Employees
-
Market Cap
-
Website
http://www.massgeneral.org/international

Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation

Phase 2
Completed
Conditions
Ganglioglioma
Astrocytoma
Ependymoma
Brain Tumor
Low Grade Glioma
Interventions
Radiation: Proton radiotherapy
First Posted Date
2011-02-02
Last Posted Date
2025-06-03
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
100
Registration Number
NCT01288235
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Be Fit in Residency: a Randomized Controlled Trial of an Activity Device Among Medicine Residents

Not Applicable
Completed
Conditions
Physical Activity
Interventions
Device: Activity device
Device: Activity monitor
First Posted Date
2011-02-01
Last Posted Date
2017-12-07
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
104
Registration Number
NCT01287208
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

Phase 2
Terminated
Conditions
Diffuse Large B Cell Lymphoma
Interventions
First Posted Date
2011-01-25
Last Posted Date
2017-05-09
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
18
Registration Number
NCT01282476
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Midostaurin (PKC412) for Locally Advanced Rectal Cancer

Phase 1
Completed
Conditions
Adenocarcinoma of the Rectum
Interventions
First Posted Date
2011-01-25
Last Posted Date
2018-12-12
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
19
Registration Number
NCT01282502
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

Does Percutaneous Tibial Nerve Stimulation (PTNS) Improve Outcomes in Patients Presenting With Fecal Incontinence

Not Applicable
Terminated
Conditions
Fecal Incontinence
Interventions
Device: Posterior tibial nerve stimulation (PTNS)
Device: Posterior tibial nerve stimulation
First Posted Date
2011-01-11
Last Posted Date
2018-01-05
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
5
Registration Number
NCT01274585
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

Study to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Elderly Subjects

Phase 1
Completed
Conditions
Elderly
Healthy
Interventions
Biological: Lactobacillus Rhamnosus GG, ATCC 53103 (LGG)
First Posted Date
2011-01-11
Last Posted Date
2017-01-11
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
15
Registration Number
NCT01274598
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults

Not Applicable
Completed
Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Substance Use Disorder (SUD)
Interventions
First Posted Date
2011-01-05
Last Posted Date
2013-03-08
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
32
Registration Number
NCT01270555

Mind-body Interventions in Cardiac Patients

Not Applicable
Completed
Conditions
Acute Coronary Syndrome
Congestive Heart Failure
Interventions
Other: Positive Psychology
Behavioral: Relaxation Response
Behavioral: Recollection
First Posted Date
2011-01-05
Last Posted Date
2011-01-21
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
60
Registration Number
NCT01270568
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

Aging and Estrogen on Cortical Function

Phase 1
Completed
Conditions
Memory Loss
Cognitive Changes
Postmenopausal Symptoms
Interventions
Drug: trasdermal placebo patch
Drug: transderman estrogen patch
Drug: placebo oral capsule
First Posted Date
2010-12-29
Last Posted Date
2018-08-22
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
38
Registration Number
NCT01268046
Locations
🇺🇸

Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, United States

Addressing Psychosocial Needs and HIV Risk in Indian MSM

Not Applicable
Completed
Conditions
HIV/STI Risk
HIV/STI Incidence
Interventions
Behavioral: Behavioral intervention
First Posted Date
2010-12-24
Last Posted Date
2015-06-01
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
96
Registration Number
NCT01266122
Locations
🇺🇸

Fenway Community Health, Boston, Massachusetts, United States

🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇮🇳

Tuberculosis Research Centre, Chennai, Tamil Nadu, India

© Copyright 2025. All Rights Reserved by MedPath